TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE IN DIAGNOSIS OF LEUKEMIA AND MALIGNANT-LYMPHOMA

被引:170
作者
KUNG, PC
LONG, JC
MCCAFFREY, RP
RATLIFF, RL
HARRISON, TA
BALTIMORE, D
机构
[1] MASSACHUSETTS GEN HOSP,DEPT PATHOL,BOSTON,MA 02114
[2] MIT,DEPT BIOL,CAMBRIDGE,MA 02139
[3] MIT,CTR CANC RES,CAMBRIDGE,MA 02139
[4] CHILDRENS HOSP MED CTR,DIV HEMATOL ONCOL,BOSTON,MA 02115
[5] SIDNEY FARBER CANC INST,BOSTON,MA
[6] HARVARD UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02115
[7] UNIV CALIF,LOS ALAMOS SCI LAB,LOS ALAMOS,NM 87544
[8] HARVARD UNIV,SCH MED,DEPT PEDIAT,BOSTON,MA 02115
关键词
D O I
10.1016/0002-9343(78)90518-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Neoplastic cells from 253 patients with leukemia and 46 patients with malignant lymphoma were studied for the presence of terminal deoxynucleotidyl transferase (TdT) by biochemical and fluorescent antibody technics. TdT was detected in circulating blast cells from 73 of 77 patients with acute lymphoblastic leukemia, 24 of 72 patients with chronic myelogenous leukemia examined during the blastic phase of the disorder and in cell suspensions of lymph nodes from nine of nine patients with diffuse lymphoblastic lymphoma. Blast cells from six of 10 patients with acute undifferentiated leukemia were TdT positive, but the enzyme was found in only two of 55 patients with acute myeloblastic leukemia. TdT was not detected in other lymphocytic or granulocytic leukemias or in other types of malignant lymphomas. The fluorescent antibody assay for TdT permits rapid and specific identification of the enzyme in single cells. The TdT assay is clinically useful in confirming the diagnosis of acute lymphoblastic leukemia, evaluating patients with blastic chronic myelogenous leukemia, and distinguishing patients with lymphoblastic lymphoma, whose natural history includes rapid extranodal dissemination, from patients with other poorly differentiated malignant lymphomas. © 1978.
引用
收藏
页码:788 / 794
页数:7
相关论文
共 36 条
[1]   LYMPHOCYTE SURFACE CHARACTERISTICS IN MALIGNANT LYMPHOMA [J].
AISENBERG, AC ;
LONG, JC .
AMERICAN JOURNAL OF MEDICINE, 1975, 58 (03) :300-306
[2]  
Baltimore D., 1976, P21
[3]  
BARCOS MP, 1975, CONFLICTS CHILDHOOD, V4, P147
[4]  
BARRETT SG, 1977, BLOOD, V50, P71
[5]   IMMUNOLOGICAL CLASSIFICATION OF LEUKEMIAS AND NON HODGKINS HEMATOSARCOMAS BASED ON T AND B CELL-MEMBRANE MARKERS WITH SPECIAL REFERENCE TO NULL CELL DISORDERS [J].
BELPOMME, D ;
LELARGE, N ;
JOSEPH, R ;
MATHE, G .
EUROPEAN JOURNAL OF CANCER, 1977, 13 (4-5) :311-319
[6]  
Braylan R C, 1975, Pathol Annu, V10, P213
[7]   CYTOCHEMICAL PROFILE OF B-LEUKEMIC AND T-LEUKEMIC LYMPHOCYTES WITH SPECIAL REFERENCE TO ACUTE LYMPHOBLASTIC LEUKEMIA [J].
CATOVSKY, D ;
GALETTO, J ;
OKOS, A ;
MILIANI, E ;
GALTON, DAG .
JOURNAL OF CLINICAL PATHOLOGY, 1974, 27 (10) :767-771
[8]  
CHANG LMS, 1971, J BIOL CHEM, V246, P909
[10]   TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE-ACTIVITY IN MALIGNANT-LYMPHOMAS [J].
DONLON, JA ;
JAFFE, ES ;
BRAYLAN, RC .
NEW ENGLAND JOURNAL OF MEDICINE, 1977, 297 (09) :461-464